Cargando…

Is multiple sclerosis a risk factor for infections?

Detalles Bibliográficos
Autores principales:	Lechner-Scott, Jeannette, Waubant, Emmanuelle, Levy, Michael, Hawkes, Chris, Giovannoni, Gavin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204651/ https://www.ncbi.nlm.nih.gov/pubmed/32571610 http://dx.doi.org/10.1016/j.msard.2020.102184

Ejemplares similares

Changes in patient and physician attitudes resulting from COVID-19 in neuromyelitis optica spectrum disorder and multiple sclerosis
por: Salama, Sara, et al.
Publicado: (2020)

The COVID-19 pandemic and the use of MS disease-modifying therapies
por: Giovannoni, Gavin, et al.
Publicado: (2020)

Vaccine hesitancy in people with multiple sclerosis
por: Lechner-Scott, Jeannette S, et al.
Publicado: (2022)

COVID-19 vaccines and multiple sclerosis disease-modifying therapies
por: Giovannoni, Gavin, et al.
Publicado: (2021)

B cell therapy and the use of RNA-based COVID-19 vaccines
por: Vishnevetsky, Anastasia, et al.
Publicado: (2021)

Biomarkers Indicative of Blood-Brain Barrier Disruption in Multiple Sclerosis
por: Waubant, Emmanuelle
Publicado: (2006)

Preventing Multiple Sclerosis: The Pediatric Perspective
por: Hardy, Duriel, et al.
Publicado: (2022)

Altered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course
por: Nourbakhsh, Bardia, et al.
Publicado: (2018)

Multiple Sclerosis Cerebrospinal Fluid Biomarkers
por: Giovannoni, Gavin
Publicado: (2006)

Rituximab in Relapsing and Progressive Forms of Multiple Sclerosis: A Systematic Review
por: Castillo-Trivino, Tamara, et al.
Publicado: (2013)

Multiple Sclerosis and Its Treatment
por: Giovannoni, Gavin, et al.
Publicado: (1999)

Modelling of the dilated sagittal sinuses found in multiple sclerosis suggests increased wall stiffness may be a contributing factor
por: Bateman, Grant Alexander, et al.
Publicado: (2022)

A Risk Score for Predicting Multiple Sclerosis
por: Dobson, Ruth, et al.
Publicado: (2016)

Systematic review and meta-analysis of the association between Epstein–Barr virus, multiple sclerosis and other risk factors
por: Jacobs, Benjamin M, et al.
Publicado: (2020)

Biosensor vital sign detects multiple sclerosis progression
por: Krysko, Kristen M., et al.
Publicado: (2020)

Cladribine Tablets for Relapsing–Remitting Multiple Sclerosis: A Clinician’s Review
por: Giovannoni, Gavin, et al.
Publicado: (2022)

Erythrocytes in multiple sclerosis – forgotten contributors to the pathophysiology?
por: Groen, Kira, et al.
Publicado: (2016)

Predicting Multiple Sclerosis: Challenges and Opportunities
por: Hone, Luke, et al.
Publicado: (2022)

BMI and low vitamin D are causal factors for multiple sclerosis: A Mendelian Randomization study
por: Jacobs, Benjamin M., et al.
Publicado: (2020)

Long COVID or post COVID-19 syndrome
por: Lechner-Scott, J., et al.
Publicado: (2021)

Fast magnetic resonance spectroscopic imaging techniques in human brain- applications in multiple sclerosis
por: Al-iedani, Oun, et al.
Publicado: (2017)

Erythrocyte microRNAs show biomarker potential and implicate multiple sclerosis susceptibility genes
por: Groen, Kira, et al.
Publicado: (2020)

An Updated Meta-Analysis of Risk of Multiple Sclerosis following Infectious Mononucleosis
por: Handel, Adam E., et al.
Publicado: (2010)

The Multiple Sclerosis Care Unit
por: Soelberg Sorensen, Per, et al.
Publicado: (2018)

No evidence for an association between alcohol consumption and Multiple Sclerosis risk: a UK Biobank study
por: Dreyer-Alster, Sapir, et al.
Publicado: (2022)

A comparison between the pathophysiology of multiple sclerosis and normal pressure hydrocephalus: is pulse wave encephalopathy a component of MS?
por: Bateman, Grant A., et al.
Publicado: (2016)

Using an animal model to predict the effective human dose for oral multiple sclerosis drugs
por: Liu, Wei, et al.
Publicado: (2022)

The challenge of comorbidity in clinical trials for multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Age-specific effects of childhood body mass index on multiple sclerosis risk
por: Hone, Luke, et al.
Publicado: (2022)

Viral pathophysiology of multiple sclerosis: A role for Epstein-Barr virus infection?
por: Maghzi, Amir-Hadi, et al.
Publicado: (2011)

HIV and lower risk of multiple sclerosis: beginning to unravel a mystery using a record-linked database study
por: Gold, Julian, et al.
Publicado: (2015)

Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIGMS study
por: Arnold, Douglas L, et al.
Publicado: (2020)

The Refinement of Genetic Predictors of Multiple Sclerosis
por: Disanto, Giulio, et al.
Publicado: (2014)

Antibodies to neurofilament light as potential biomarkers in multiple sclerosis
por: Puentes, Fabiola, et al.
Publicado: (2021)

The effect of cladribine on immunoglobulin levels compared to B cell targeting therapies in multiple sclerosis
por: Lycett, Mitchell J, et al.
Publicado: (2023)

Polygenic risk score prediction of multiple sclerosis in individuals of South Asian ancestry
por: Breedon, Joshua R, et al.
Publicado: (2023)

Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls
por: Tremlett, Helen, et al.
Publicado: (2016)

Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine
por: Pakpoor, Julia, et al.
Publicado: (2012)

Family Perspectives on Clinical Research for Pediatric Multiple Sclerosis: Enhancing Equity
por: Mandel, Leslie A, et al.
Publicado: (2021)

Recommendations for observational studies of comorbidity in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ht68vmhclk09877hj0evmb5dac